| 000 | 005970000a22001690004500 | ||
|---|---|---|---|
| 001 | 9010 | ||
| 090 | _a9010 | ||
| 100 | _a20090630d k||y0pory50 ba | ||
| 101 | _aeng | ||
| 102 | _aGB | ||
| 200 |
_aThe transition from agonist to antagonist activity _esymmetry and other considerations _fDavid J. Triggle |
||
| 300 | _aCapítulo de monografia | ||
| 463 |
_aed. lit. Camile G. Wermuth _cLondon _d2003 _e2nd ed _nAcademic Press _pp. 459-475 _tThe practice of medicinal chemistry _0547 |
||
| 606 |
_92723 _aQuímica farmacêutica |
||
| 606 |
_93085 _aTecnologia farmacêutica |
||
| 676 |
_a615.19 P912 _v2ªed |
||
| 700 |
_929587 _aTriggle _bDavid J. |
||
| 942 |
_cANA _n0 |
||